Hepatitis ASymptoms, Doctors, Treatments, Advances & More
Hepatitis A Overview
Learn About Hepatitis A
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
CHRU Claude Huriez
Philippe Mathurin is a Gastroenterologist practicing medicine in Lille, France. Mr. Mathurin is rated as an Elite expert by MediFind in the treatment of Hepatitis A. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis A, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant.
Pierre Van Damme practices practicing medicine in Antwerpen, Belgium. Mr. Van Damme is rated as an Elite expert by MediFind in the treatment of Hepatitis A. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pertussis, Hepatitis A, Tetanus, and Human Papillomavirus Infection.
Tatsuo Kanda practices practicing medicine in Koriyama, Japan. Mr. Kanda is rated as an Elite expert by MediFind in the treatment of Hepatitis A. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis A, Hepatitis C, Liver Transplant, and Hepatectomy.
Summary: This study will collect blood plasma and white blood cells from individuals using a procedure called apheresis. Apheresis is a method of collecting larger quantities of certain blood components that can safely be collected through a simple blood draw. The blood components will be used in laboratory research studies. Patients 18 years of age and older who are currently enrolled in a NIH clinical re...
Summary: This study is being done to understand and measure how the immune system responds to and remembers different types of vaccines. To do this, four vaccines approved by the U.S. Food and Drug Administration (FDA) will be given simultaneously to participants. Participants will be volumteers who are healthy adults (18 years old or older) and willing to receive the yearly trivalent inactivated influenza...


